Blackstone DE of $1.32 beats by $0.06, revenue of $3.06B misses by $150M (BX:NYSE)

Blackstone (BX) reported Q3 distributable earnings of $1.32 per share, exceeding estimates by $0.06, while revenue of $3.06B missed expectations by $150M. AUM grew to $1.37T. The company declared a dividend of $1.12 per share. According to reports, Blackstone may explore minority stakes in NFL teams and a London office lease with Stripe.

Original reporting
Published Oct 22, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BX
Bearish
high confidence
Mentioned
$BX
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$BXBearishHigh
01

Why it matters

Revenue miss may trigger a sell‑off, while the dividend and EPS beat could cushion the move.

02

Market read

First‑report earnings for a major asset manager; material numbers likely to move the stock.

03

What to watch

A $1.12 dividend announcement may attract income‑focused investors despite the miss.

Relevance 8/10Novelty 8/10Timing: pre‑market

Background

Blackstone's Q3 press release provides the first public disclosure of its earnings and dividend details.

Company-level read

Ticker impact

$BXBearishHigh confidence
Context

Blackstone reported Q3 earnings: EPS $1.32 beat by $0.06, revenue $3.06B missed by $150M.

Expected impact

likely downward pressure as market prices in the revenue shortfall

Evidence & confidence

Revenue miss of $150M on a $3B base is material for a large-cap asset manager and can trigger a sell‑off.

Market effects

May prompt reassessment of asset‑manager revenue forecasts across the sector.

US equity markets could see modest downside pressure in financials.

Limited to investors tracking large‑cap alternative‑asset managers.

Counterpoint

The EPS beat could offset revenue concerns, supporting a short‑term rally.

Key entities

  • Blackstone

    Large‑cap alternative asset manager (ticker BX).

Related articles

$BXHigh

Blackstone's 16% Stake In IIFL Finance To Strengthen Capital Base

Blackstone Inc. plans to acquire a 16% stake in IIFL Finance, investing Rs 5,000 crore to boost its capital base. Fitch Ratings expects this to double IIFL Finance's Tier 1 capital ratio to 25.7% by September 2026, enhancing its funding flexibility and supporting growth plans. The transaction is not expected to immediately impact IIFL Finance's ratings or business model, which focuses on secured lending.

$PFEMedAI 8/10

Your Questions Answered: GLP-1 Deals, FDA Approvals, and Manufacturing Buildout

Pfizer and Blackstone Life Sciences agreed to co-fund berobenatide, a GLP-1 drug for weight management, with Blackstone covering up to $1.5B in development costs. Pfizer retains control. J&J acquired Ollin Biosciences for $2.2B, Lilly acquired Calytrix Bio for up to $1.5B, and Sanofi partnered with Seawolf Therapeutics. Gilead licensed obeldesivir to generic manufacturers for Ebola prevention. The FDA approved Novartis' Cosentyx for polymyalgia rheumatica and Roche's Wilserdly for breast cancer.